What is he best known for?
The fields of study he is best known for:
- Bacteria
- Gene
- Antibiotics
His main research concerns Microbiology, Escherichia coli, Klebsiella pneumoniae, Internal medicine and Antibacterial agent.
His Microbiology research includes elements of Plasmid, Molecular epidemiology and Enterobacteriaceae.
Álvaro Pascual has researched Enterobacteriaceae in several fields, including Bacteria and Virology.
Many of his research projects under Internal medicine are closely connected to Context with Context, tying the diverse disciplines of science together.
His research integrates issues of Mutation, Cefoxitin and Porin in his study of Antibacterial agent.
His Drug resistance research integrates issues from Ciprofloxacin and Multilocus sequence typing.
His most cited work include:
- Quinolone resistance from a transferable plasmid (918 citations)
- Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. (554 citations)
- Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients (413 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Microbiology, Escherichia coli, Antibacterial agent, Klebsiella pneumoniae and Antimicrobial.
His Microbiology research is multidisciplinary, incorporating elements of Plasmid, Enterobacteriaceae and Acinetobacter baumannii.
His work carried out in the field of Escherichia coli brings together such families of science as Mutant, Fosfomycin, Bacteria, Drug resistance and Virulence.
His studies in Antibacterial agent integrate themes in fields like Extracellular and Intracellular.
His Antimicrobial research includes themes of Antibiotics, Antibiotic resistance and Intensive care medicine.
His Antibiotic resistance research focuses on Internal medicine and how it connects with Surgery.
He most often published in these fields:
- Microbiology (75.93%)
- Escherichia coli (25.93%)
- Antibacterial agent (14.40%)
What were the highlights of his more recent work (between 2017-2021)?
- Microbiology (75.93%)
- Internal medicine (15.64%)
- Klebsiella pneumoniae (14.61%)
In recent papers he was focusing on the following fields of study:
Microbiology, Internal medicine, Klebsiella pneumoniae, Acinetobacter baumannii and Escherichia coli are his primary areas of study.
His studies deal with areas such as Plasmid and Mutant as well as Microbiology.
Internal medicine is closely attributed to Bacteremia in his study.
His work on Enterobacter cloacae as part of general Klebsiella pneumoniae study is frequently linked to Context, bridging the gap between disciplines.
The study incorporates disciplines such as clone, Quorum sensing, Quorum Quenching and Acinetobacter in addition to Acinetobacter baumannii.
His study in Escherichia coli is interdisciplinary in nature, drawing from both Ciprofloxacin, Broth microdilution, Drug resistance and Chromosomal mutations.
Between 2017 and 2021, his most popular works were:
- Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. (222 citations)
- Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations (49 citations)
- Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae. (24 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Antibiotics
- Gene
The scientist’s investigation covers issues in Microbiology, Klebsiella pneumoniae, Antibiotic resistance, Internal medicine and Acinetobacter baumannii.
He has included themes like Ceftazidime and Avibactam in his Microbiology study.
The concepts of his Klebsiella pneumoniae study are interwoven with issues in Enterobacteriaceae, Multilocus sequence typing, Sepsis and Pneumonia.
His Antibiotic resistance study incorporates themes from Ciprofloxacin, Biofilm, SOS response, SOS Response and Quinolone.
His Internal medicine research is multidisciplinary, relying on both Bacteremia and Fosfomycin.
Álvaro Pascual combines subjects such as Infectivity, clone, Gene and Quorum Quenching with his study of Acinetobacter baumannii.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
